baber/WOPTO huggingface dataset:
Patent JP-H11504441-A (JP)
IPC: G02F1/23
Filed: 1996-05-23
Abstract: This invention provides a complementary color polarizer using a single polarizing film followed by a stack of two or more retarders. In a preferred embodiment, the color polarizers of this invention produce orthogonally polarized complementary primary colors (red/cyan, green/magenta, or blue/yellow). This invention further provides color filters which utilize the color polarizers of this invention in combination with a polarization separator to separate the orthogonally polarized colors. The polarization separator can be passive, such as a polarizing beam splitter, or active, such as a switchable polarizer. The switchable polarizer can employ a nematic or a smectic liquid crystal cell. Two color filters of this invention can be cascaded to provide a three color (RGB) filter with an off-state. In combination with a monochrome display or camera, the color filters of this invention provide color displays or cameras.
Patent JP-H11507859-A (JP)
Title: 空気検出器
IPC: G01N29/00
Filed: 1997-01-23
Abstract: (57)【要約】
本発明は、液体貫流チューブ内の過剰な空気を検出する装置を提供する。装置は、超音波信号を送信する超音波送信器と、超音波信号を受信する超音波受信器とを含む。超音波送信器と超音波受信器とはIVチューブによって分離される。装置はさらに、超音波送信器を始動させるために少なくとも２つの送信信号を生成する回路手段と、受信信号を検出する回路手段とを備える。受信信号がIVチューブ内に空気が存在することを示すか液体が存在することを示すかを決定する手段が配備される。装置はさらに、空気塞栓の予測で大きな安全要因を与える線形検出ではなく、対数による流体内の空気の検出に依存する。
Patent JP-H10503888-A (JP)
Title: 変成器を介する回路バイアス
IPC: H01F19/06
Filed: 1996-05-07
Abstract: (57)【要約】
増幅器モジュール回路において、入力変成器（Ｔ１）が入力信号（ＩＳＵ）を変換入力信号（ＩＳＢ）に変換し、この変換入力信号を一対の増幅器（ＡＭＰＡ，ＡＭＰＢ）に供給する。この入力変成器（ＴＩ）の磁心には、入力信号変換用の巻線（Ｗ１，Ｗ２）に加えて前記一対の増幅器（ＡＭＰＡ，ＡＭＰＢ）をバイアスする補助巻線（Ｗ３）が設けられている。この補助巻線（Ｗ３）の両端が前記一対の増幅器（ＡＭＰＡ，ＡＭＰＢ）の入力トランジスタ（ＱＡ，ＱＢ）に直流結合されている当該補助巻線上のタップ（ＸＴ）に直流バイアス電圧（ＶＢ）が供給される。
Patent JP-2000513842-A (JP)
Title: プログラム可能記憶装置を有する制御装置の作動方法
IPC: F02D41/24
Filed: 1997-02-27
Abstract: (57)【要約】
制御装置動作に対するデータとプログラムを記憶するためのプログラム可能記憶装置（２２）を有する制御装置の作動方法が記載されている。この方法は、プログラム可能記憶装置のプログラミングと共にプログラミング過程を記録するデータを記憶することを特徴とする。
Patent JP-H10510592-A (JP)
Title: 成形された銅製品の作製プロセス
IPC: C01G3/00
Filed: 1996-11-12
Abstract: (57)【要約】
本発明は銅含有物質から直接、成形された銅製品を作製するプロセスに関し、以下を包含する：(A)上記銅含有物質を少なくとも１つの水性浸出液の有効量と接触させて、銅イオンを上記浸出液に溶解し、そして銅の含有量の多い水性浸出液を形成する工程；(B)上記銅の含有量の多い水性浸出液を少なくとも１種の水に不溶な抽出剤の有効量と接触させ、銅イオンを上記銅の含有量の多い水性浸出液から上記抽出剤の方に移動させて、銅の含有量の多い抽出剤および銅の枯渇した水性浸出液を形成する工程；(C)上記銅の含有量の多い抽出剤を上記銅の枯渇した水性浸出液から分離する工程；(D)上記銅の含有量の多い抽出剤を少なくとも１種の水性のストリッピング溶液の有効量と接触させ、銅イオンを上記抽出剤から上記ストリッピング溶液に移動させて銅の含有量の多いストリッピング溶液および銅の枯渇した抽出剤を形成する工程；(E)上記銅の含有量の多いストリッピング溶液を上記銅の枯渇した抽出剤から分離する工程；(F)上記銅の含有量の多いストリッピング溶液をアノードとカソードとの間に流動させ、そして有効量の電圧を上記アノードと上記カソードとの間に印加して、上記カソード上に銅粉末を析出させる工程；(G)上記銅粉末を上記カソードから取り出す工程；および(H)上記銅粉末を、押し出し、鍛造し、または成型し、上記成形された銅製品を形成する工程。
Patent JP-2001514663-A (JP)
Title: アルツハイマー病を処置または予防するための方法
IPC: A61K33/24
Filed: 1998-03-12
Abstract: (57)【要約】
食物中の代謝可能な炭水化物のレベルを制限する工程、および／または血清インシュリンレベルを低減する薬剤の有効量を患者に投与することにより、アルツハイマー病を処置または予防する方法が開示される。
Patent JP-H10508270-A (JP)
Title: 多機能の沖合探査及び／又は開発の掘削方法及び装置
IPC: B63B35/44
Filed: 1997-01-27
Abstract: (57)【要約】
単一のデリック（４０）と、該デリック（４０）内の多数の管作業ステーションとを有する多機能型の掘削船（３０）及びその方法及びその装置であり、主たる掘削作業がデリック（４０）から行なわれ、これと同時に、補助的な掘削作業が、同一のデリック（４０）から行われ、主たる掘削作業の臨界的な経路の長さを短くすることができる。
Patent JP-2000510516-A (JP)
Title: 非毒性開始剤、開始剤を含む架橋性オルガノ官能基を含有する樹脂、及び安定な非毒性ポリマーを製造するためのそれらの使用
IPC: C09D183/04
Filed: 1998-04-14
Abstract: (57)【要約】
発明は、開始剤系の存在において照射下で架橋可能な非毒性樹脂を調製する新規な方法に関する。該樹脂は、オルガノ官能基を有するモノマー、オリゴマー及び／又はポリマーを含む有機及び／又はシリコンタイプの組成物から調製し、毒性が低いオニウム塩であって、それのカチオン性構造が［（ＣＨ（ＣＨ 3 ） 2 −Φ−）−Ｉ−（−Ｒ 1 ）］ + （Ｉ）である開始剤系の存在において架橋させる。
Patent JP-2002504277-A (JP)
Title: 非線形分離および線形再接合に基づくオーバサンプルされたディジタル・アナログ変換器
IPC: H03M3/04
Filed: 1998-04-16
Abstract: (57)【要約】
誤り整形デジタル・アナログ(D/A)変換システム(100)であり、分離器(102)、１組のD/A変換器(104，108)、１組のオプションのアナログ・フイルタ(106，108)、集計機器(112)および１個のオプションのアナログ・フイルタ(114)から構成される。分離器(102)はデジタル入力信号を、その中の１個のみがシステムの帯域内において顕著な電力を持つ１組の低分解能信号へ分離する。これらの信号はミスマッチ整形D/A変換器(104，108)によりD/A変換され、いくつかの実施例ではアナログ・フイルタ(106，110)によりろ波され、次いで集計機器(112)により加算される。使用されたD/A変換器(104，108)の不完全性は信号帯域内で非常に小さな誤りの原因となるが、そのような誤りはデジタル入力信号に本質的に非相関である。このD/A変換器システムは、そこでは歪みが信号帯域内においては非常に小さな電力しか持たない雑音要素に変換されるスケールド・エレメントD/A変換器に比肩する。
Patent JP-2001509821-A (JP)
Title: 溶媒の存在下での過酸化水素によるオレフィン性化合物のエポキシ化方法
IPC: C07D301/12
Filed: 1998-03-26
Abstract: (57)【要約】
酸素化された有機溶媒中のチタンアルコキシドおよび／又はチタノセンの溶液でシリカを含浸することによって製造された、シリカ支持されたチタン触媒を用いる、溶媒（好ましくはＣ 1 〜Ｃ 8 アルコール）の存在下での、過酸化水素によるオレフィン性化合物のためのエポキシ化方法。
Patent JP-2001525664-A (JP)
Title: 融合タンパク質を使用するアミド化されたペプチドの製造方法
IPC: C12R1/19
Filed: 1998-05-01
Abstract: (57)【要約】
組換え手段によるペプチドの製造方法、特に、ただしこれに限定されるものではないが、アミド化のようなカルボキシ末端の修飾を持つペプチドの製造方法が提供される。
Patent JP-2001502591-A (JP)
Title: 鼾掻き防止及び鼻補形器
IPC: A61F5/08
Filed: 1998-05-08
Abstract: (57)【要約】
本発明は着用することにより、鼾掻きを防止し鼻の形を補正し得るようにした鼾掻き防止及び鼻補形器に関する。本発明は、各鼻腔の内側上部に位置し、鼻筋を押し付けて鼻筋を高くし、鼾掻きを防止するための一対の内側圧迫具１１１が両側の弾持幹１１３の上端部にそれぞれ付着された挿入補形手段１１０と、前記内側圧迫具１１１の位置を調節するための位置調節手段１００とを含んで構成される。本発明は圧迫具を用いて鼻筋を鼻腔の内部から外側に押し付けて鼻腔の体積を増やすことにより、鼾掻きを防止するとともに、鼻筋が立てられるように誘導するという効果を奏する。
Patent JP-2002500803-A (JP)
Title: 並列トラックにデータを記録する装置
IPC: G11B15/07
Filed: 1999-03-22
Abstract: (57)【要約】
装置は、磁気テープ(10)上の並列トラックにデータを書込むため、幅方向(y)に相互に隣接している８個の書込ユニット(21-28)を持つ薄膜磁気ヘッド(20)を具える。スイッチング手段(70)は、ノーマルモードから結合モードへ切換えるためのスイッチ(SW)を具える。ノーマルモードでは、スイッチ(SW)が第１位置(D1)にあり、スイッチング手段(70)が、第１データ信号(S1)を第１書込ユニット(21)に、第２データ信号(S2)を第２書込ユニット(22)に、等のように結合し、これにより、ノーマルモードでは８個のトラック(T21-T28)がテープ(10)に書込まれ、これが第１トラック密度になる。結合モードでは、スイッチ(SW)が第２位置(D2)にあり、スイッチング手段(70)が、第１データ信号(S1)を第１及び第２書込ユニット(21及び22)に、第２データ信号(S2)を第３及び第４書込ユニット(23及び24)に、等のように結合する。これにより結合モードでは、４個のトラック(T1-T4)がテープ(10)に書込まれ、これが第１トラック密度の半分の第２トラック密度になる。この第２トラック密度は、古い世代の装置（図示されていない）の磁気ヘッド(2)の書込ユニットの密度に対応する。
Patent MD-20060119-A (MD)
Title: Surgical suturing device
Inventor: ŢÎBÎRNĂ Gheorghe
IPC: A61B17/068
Filed: 2006-04-13
Abstract: The invention refers to the medical equipment, particularly to a surgical device for suturing internal organ wounds.The surgical suturing device consists of a body (1), a brace cassette (2), a brace pusher (3), a brace pusher guide (10), a lock arm (4), a brace pusher guide moving mechanism (5), a brace pusher moving screw (6), an axle for interconnecting the lock arm with the body (7), lock arm connection through holes (8) and a lock arm blocking screw (9). Novelty consists in that the brace cassette (2), the brace pusher (3), the lock arm (4) and the brace pusher guide (10) are made in the form of arc.
Patent MD-20070049-A (MD)
Title: Catalyst for water purification from organic compounds
Inventor: AZZOUZ ABDELKRIM
IPC: B01J21/16
Filed: 2007-02-26
Abstract: The invention relates to water treatment technologies and can be used for purification of potable and sewage water, for equipment disinfection in the food industry, including sterilization and degasification of water solutions.The catalyst for water purification from organic compounds contains a base of an anionic support of montmorillonite argil, not containing quartz, cristobalite and organic impurities, bound with metal cations, at the same time the anionic argillous support is bound with cations chosen from transition metals, for example, with iron, cobalt, nickel, copper cations or with sodium cations in the acid form:(Mt-)mMetr (m+),where Mt- is the anionic argillous support;Metr (m+) - cation of transition metal;m - cation valence.
Patent MX-152157-A (MX)
Inventor: WADSWORTH LARRY CLIFTON
IPC: B01D39/16
Filed: 1982-03-12
Abstract: A process of manufacturing an electrostatically charged filtration medium is disclosed. A web made of nonconductive thermoplastic fibers is contacted on each side with a more conductive web to form a combined web. The combined web is charged with electrically charged particles from corona charging elements on oppposite sides of the web. The charging elements are operated at a voltage of from 5 to 25 kV but with opposite polarity.
Patent NZ-195753-A (NZ)
Title: Alkylation of organic compounds
Inventor: BOUISSET M
IPC: C07C51/353
Filed: 1980-12-04
Abstract: Process for introducing a substituent selected from branched- or straight-chain alkyl radicals having from 1 to 12 carbon atoms, aralkyl or cycloalkyl radicals in which the alkyl moiety has from 1 to 4 carbon atoms, into a carbon chain bearing a stable functional group the said carbon chain having at least one proton in  alpha -position in relation to this functional group, process whereby, in a first step, this carbon chain is reacted with a complex base comprising a mixture of alkali metal amide and alkali metal alcoholate suspended in an anhydrous organic solvent to provide temporarily a carbanion, then in a second step this carbanion is reacted in an anhydrous organic solvent with an alkyl, aralkyl or cycloalkyl halide corresponding to the substituent to be introduced.
Patent NZ-202759-A (NZ)
Title: Esters of the michael addition homopolymers of acrylic acid and polymers therefrom
Inventor: EMMONS W D
IPC: C08F20/28
Filed: 1982-12-09
Abstract: Polymers comprising mers of esters of one or more alcohols and more than one of the acids represented by the formula CH2=CHCO2(CH2CH2CO2)nH, or ester forming derivatives thereof, wherein the average value of n, n, is 0.1 or greater, are useful as or in coating compositions, binders or adhesives. Esters of one or more alcohols other than C1 to C10 alkyl monohydroxylates and more than one of the above acids or derivatives having the same values of n are useful as or in monomers, reactive diluents, modifiers or crosslinkers.
Patent NZ-203832-A (NZ)
Title: N-(1,3-dithiolan-2-ylidene)-anilines and pharmaceutical compositions
Inventor: HARRISON B L
IPC: C07D339/06
Filed: 1983-04-08
Abstract: N-(1,3-dithiolan-2-ylidene)-4-alkylanilines are useful as anti-inflammatory agents, as analgesic agents and as antiasthmatic agents. The compounds involved can be prepared by the reaction of an appropriate 4-alkylaniline with a methyl(1,3-dithiolan-2-ylidene)sulfonium salt or with carbon disulfide and ethylene dibromide in the presence of a base.
Patent NZ-206700-A (NZ)
Title: Improvement in genetic production of proteins using promoter/operator/ribosome binding site sequence
Inventor: DWORKIN M-B
IPC: C07K14/555
Filed: 1983-12-22
Abstract: The present invention relates to the combination of the promoter/operator region of the tryptophan operon of Serratia marcescens with a synthetic ribosome binding sequence, an expression plasmid which contains this sequence and in which the above sequence is followed by the only Hind III cleavage site in the plasmid, into which site the gene to be expressed can be inserted, and to production plasmids for the expression of eukaryotic gene products in prokaryotes, especially for the preparation of leucocyte interferon.
Patent NZ-213325-A (NZ)
Title: Topical percutaneous anaesthetic containing gelling agent
Inventor: MCCAFFERTY D
IPC: A61K31/245
Filed: 1985-09-02
Abstract: A composition for topical percutaneous anaesthesia comprises an anaesthetic e.g. amethocaine, dispersed in an aqueous gel e.g. methylcellulose or sodium carbopol and water. Amethocaine stability is enhanced by the gel matrix.
Patent NZ-215851-A (NZ)
Title: Permanent hair waving composition containing pantethine or pantetheine
Inventor: SMITH W P
IPC: A61K8/46
Filed: 1986-04-16
Abstract: Pantethine and pantetheine in permanent waving operations for hair to increase waving efficiency.
Patent NZ-222842-A (NZ)
Title: Surgical sponges containing polymeric x-ray detectable marker compositions
Inventor: DYER J
IPC: A61B19/00
Filed: 1987-12-08
Abstract: Woven and nonwoven fabrics for use in surgical procedures are printed with a radiopaque polymeric composition which bonds to the surface of the fabric. The composition is applied in a visually distinctive pattern, or may assume the pattern of the underlying fabric. The polymeric composition is readily recognized in an X-ray image and provides an improved means for detecting a surgical sponge inadvertently left in a patient. Preferred compositions are latex or plastisols of a printable viscosity containing from 15 to 70% by weight BaSO4 having a particle size greater than about 5 microns.
Patent NZ-233430-A (NZ)
Title: Polysiloxane coating for glass
Inventor: AKITSUGU KURITA
IPC: C08L83/04
Filed: 1990-04-24
Abstract: An abrasion-concealing agent for glass containers, which comprises (A) a polyorganosiloxane and (B) a volatile polydimethylsiloxane, a glass container in which abrasions on the surface thereof have been concealed by the abrasion-concealing agent, and a method for concealing abrasions on a glass container by using the abrasion-concealing agent. The abrasion-concealing agent has excellent abrasion-concealing properties, film strength, water resistance, safety, workability and resistance to an aqueous alkaline solution washing, and does not cause any damage to labels on glass containers in the coating process.
Patent NZ-234529-A (NZ)
Title: Methods and compositions for chromosome-specific staining.
Inventor: GRAY JOE W
IPC: C12N15/09
Filed: 1990-07-16
Abstract: Methods and compositions for staining based upon nucleic acid sequence that employ nucleic acid probes are provided. Said methods produce staining patterns that can be tailored for specific cytogenetic analyses. Said probes are appropriate for in situ hybridization and stain both interphase and metaphase chromosomal material with reliable signals. The nucleic acid probes are typically of a complexity greater than 50 kb, the complexity depending upon the cytogenetic application. Methods and reagents are provided for the detection of genetic rearrangements. Probes and test kits are provided for use in detecting genetic rearrangements, particularly for use in tumor cytogenetics, in the detection of disease related loci, specifically cancer, such as chronic myelogenous leukemia (CML) and for biological dosimetry. Methods and reagents are described for cytogenetic research, for the differentiation of cytogenetically similar but genetically different diseases, and for many prognostic and diagnostic applications. Further provided is a method of preparing and applying chromosome-specific single-stranded nucleic acid probes to double stranded target DNA.
Patent NZ-243180-A (NZ)
Title: Aromatic ether derivatives and antiviral compositions thereof
Inventor: GIRIJAVALLABHAN VIYYOOR M
IPC: C07D307/42
Filed: 1992-06-17
Abstract: A compound represented by formula I Ar1-O-M-O-Ar2   I    wherein Ar1 and Ar2 are independently substituted phenyl or substituted pyridinyl, the substituents on said phenyl or pyridinyl being independently selected from one, two or three of (C1-C10) alkyl, (C1-C10) alkoxy, halogen, carbamyl, dialkylcarbamyl, (C1-C10)-alkoxycarbonyl, oxazoyl, and (C1-C10) alkyl substituted by halogen, (C1-C10) alkoxy, hydroxy, or (C1-C10) alkoxycarbonyl; <CHEM>     (C4-C8) alkylene, (C4-C8) alkenylene or     (C4-C8)- alkynylene;     O is oxygen;     R min  is (C1-C3) alkyl or H;     A is oxygen or sulfur; Q is selected from hydrogen, halogen, nitro, (C1-C6) alkyl, (C1-C6) perhaloalkyl, (C1-C6) alkylthio (C1-C6) alkyl sulfonyl; the dotted lines in M-3 and M-4 between carbons 2, 3 and 4, and 5 and 6 mean that the bonds between carbons 2 and 3, and 3 and 4, and 5 and 6, may each be a single or double bond;     n = 1 or 2     m = 1 or 2     p = 0 or 1 and     or pharmaceutically acceptable salts thereof. as well as pharmaceutical compositions containing the compounds and the use of the compounds of formula I for preparation of a medicament for methods of treating or preventing viral infections, especially picornaviral infections, are disclosed.
Patent NZ-246385-A (NZ)
Title: Cheese production; size of fat balls within the milk reduced to below 2.5 microns
Inventor: VISZLAI BELA
IPC: A23C9/15
Filed: 1992-12-23
Abstract: PCT No. PCT/HU92/00062 Sec. 371 Date Nov. 18, 1993 Sec. 102(e) Date Nov. 18, 1993 PCT Filed Dec. 23, 1992 PCT Pub. No. WO93/12663 PCT Pub. Date Jul. 8, 1993.Process for the production of cheeses by standardizing, in the course of which milk is skimmed, the separated cream is treated, then the fat content of the kettle milk is adjusted by means of the treated cream, then it is cold-ripened, afterwards culturing, adding of additives, in certain cases curdling take place, then, it is coagulated, chopped, heated; the separation of whey, shaping, pressing, salting take place, then it is ripened; wherein the size of fat balls within milk the milk is reduced to below 2,5 micron by ultrasonic treatment or by treatment in Venturi-tube, in ball and tube mill, or in atomizer. The diameter of the fat balls is reduced to 0,6-1,3 micron. The ultrasonic treatment of the cream is carried out at a vawe length of 10,000-50,000 Hz. The duration of the ultrasonic treatment of the cream is up to 300 sec. The skimmed milk is pasteurized. The kettle milk is cold-ripened for 4-10 hours. Sterilized milk and cream are heated to a temperature of 28 DEG -40 DEG  C. prior to culturing.
Patent NZ-277062-A (NZ)
Title: Door closer: door rotates a spindle in closer housing which drives a cam follower along a track therein against a resiliently biased reciprocal piston: torque at spindle greater when door closed than when open
Inventor: GUTHRIE DUNCAN RICHARD
IPC: E05F3/10
Filed: 1994-12-06
Abstract: PCT No. PCT/GB94/02668 Sec. 371 Date Apr. 17, 1996 Sec. 102(e) Date Apr. 17, 1996 PCT Filed Dec. 6, 1994 PCT Pub. No. WO95/16845 PCT Pub. Date Jun. 22, 1995A door closer comprises a housing (21) in which a compression spring (23) urges a piston (22) in one direction, an operating spindle (18) in the housing defining an axis (19) about which an arm mechanism (52) connected to the housing is angularly movable to effect movement of the piston in the opposite direction. Connected between said axis (19) and the piston (22) is a linkage mechanism which provides that, in use, maximum torque is exerted on the arm mechanism at the near closed position of the door. The linkage mechanism can have a pivotal connection (27) between links (25, 26) thereof constrained to follow a continuous curve by means of a cam track (30, 31) or an additional link (48).
Patent NZ-299149-A (NZ)
Title: Eliciting an immune response to helicobacter by administering helicobacter epitopes to mucosal surfaces
Inventor: MICHETTI PIERRE
IPC: A61K39/00
Filed: 1993-11-02
Abstract: Method of eliciting in a mammalian host a protective immune response to Helicobacter infection by administering to the host an immunogenically effective amount of a Helicobacter urease or urease subunits as antigen. Vaccine compositions are also provided.
Patent NZ-302312-A (NZ)
Title: Gambling chip with pressure pad ink markings and varnish layer
Inventor: MAUZAC OLIVIER
IPC: B41F17/00
Filed: 1996-02-13
Abstract: PCT No. PCT/FR96/00228 Sec. 371 Date Oct. 2, 1996 Sec. 102(e) Date Oct. 2, 1996 PCT Filed Feb. 13, 1996 PCT Pub. No. WO96/25066 PCT Pub. Date Aug. 22, 1996A gambling chip includes a decorative pattern provided on at least one side thereof and on an edge thereof. The pattern is formed by pressure pad marking, i.e., applying an ink pattern to a deformable head and stamping the pattern on the chip. Repeated stamping of different color inks can create different patterns. A layer of varnish is also applied to the chip, either between ink layers or above or below all of the ink layers.
Patent NZ-305862-A (NZ)
Title: A process and apparatus for manufacturing a metal can with a foil closure membrane
Inventor: GRABHER WERNER
IPC: B65B7/28
Filed: 1996-03-30
Abstract: The tin can is closed by a paper, plastic or metal-foil membrane (2) on at least one end face in such a way that the outer side of the foil edge region (5) raised in the direction of the can's axis (A) is joined to the essentially cylindrical inner surface of the wall of the can (1) to form a seal, without covering the wall edge of the can. The membrane foil (2) with the raised foil edge region (5) is introduced into the can and forced against the inner wall of the can (1) by a die (8) with an expandable periphery (17). Heat is then applied to create a sealing join between the raised foil edge region (5) and the inner wall of the can (1) without any external pressure-absorbing device.
Patent NZ-320541-A (NZ)
Title: Extended long life juice carton structure and method of construction
Inventor: KINSEY JOE L
IPC: B65D65/40
Filed: 1996-10-11
Abstract: An extend long life juice carton structure is provided which has low oxygen permeability, is leak free, has minimal flavor loss, and excellent bulge resistance and durability characteristics without sacrificing the ability to skive the side seam or use hydrogen peroxide as a sterilizing substance. The container structure has a polyamide polymer layer, a layer of ethylene vinyl alcohol copolymer with an ethylene comonomer content of 27-32 mole %, and a thin matte side layer polyolefin polymer.
Patent NZ-324100-A (NZ)
Title: Luminal cholecystokinin-releasing factor
Inventor: GREEN GARY M
IPC: C07K16/24
Filed: 1996-10-23
Abstract: This invention describes a cholecystokinin-releasing polypeptide (approx. 8 kDa) isolated from rat intestinal secretions which binds specifically with labeled antibodies. Also claimed is a recombinant vector comprising a DNA segment, which encodes the specific cholecystokinin-releasing polypeptide, and the use of said polypeptide in the manufacture of a medicament for suppressing appetite, stimulating gallbladder contraction or treating gallbladder disease related to gallstone formation.
Patent NZ-334312-A (NZ)
Title: Use of mononuclear phagocytes and a binding agent in therapeutic drug delivery
Inventor: LEWIS CLAIRE ELIZABETH
IPC: A61K47/48
Filed: 1997-10-08
Abstract: The application relates to the exploitation of the migratory behaviour of mononuclear phagocytes with a view to targeting therapeutic drug delivery. The application further concerns the attachment or incorporation of a therapeutic agent to or into a mononuclear phagocyte and the subsequent migration of the munonuclear phagocyte to a target area.
Patent NZ-337827-A (NZ)
Title: Use of GluR5 receptor antagonists in the manufacture of medicaments for treating pain
Inventor: BLEAKMAN DAVID
IPC: C07D401/12
Filed: 1998-04-06
Abstract: The use of a selective GluR5 receptor antagonist for the manufacture of a medicament for the treatment of pain.
Patent NZ-500077-A (NZ)
Title: Humanized antibodies to vascular endothelial growth factor (VEGF) and methods for their preparation.
Inventor: WELLS J A
IPC: C12P21/08
Filed: 1998-04-03
Abstract: A humanized antibody to vascular endothelial growth factor (VEGF) and a method for rapidly producing and identifying framework mutations which improve the binding of humanised antibodies to their cognate antigens is described. Non-human complimentary determining regions (CDRs) are grafted onto a human V1 kappa I-V HIII framework.  Random mutagenesis of a small set of critical framework residues is also performed followed by monovalent display of the resultant library of antibody molecules on the surface of filamentous phage.  The optimal framework sequences are then identified by affinity-based selection.  The selected antibodies can be further mutated so as to replace vernier residues which sit at the VL-VH interface by residues that match the non-human parent antibody.  The methods described can be applied to any non-human antibody. FIG._3 shows a phagemid construct for surface display of Fab-pIII fusions on the phage.  The phagemid construct encodes a humanized version of the Fab fragment for antibody A4.6.1 fused to a portion of the M13 gene III coat protein. The fusion protein consists of the Fab fragment joined at the carboxyl terminus of the heavy chain to a single glutamine residue (from suppression of an amber codon in supE E. coli), then the C-terminal region of the gene III protein (residues 249-406). Transformation into F+ E. coli, followed by superinfection with M13KO7 helper phage, produces phagemid particles in which a small proportion of these display a single copy of the fusion protein.